Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cardiovascular Research

• Publication date

  2005-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CARDIORES.2005.03.001PMID 15949473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction.

  2004cited by this paper
• Review of aldosterone- and angiotensin II-induced target organ damage and prevention.

  2004cited by this paper
• Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.

  2003cited by this paper
• Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure.

  2003cited by this paper
• Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthesis in Patients With First Anterior Acute Myocardial Infarction

  2003cited by this paper
• Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition

  2003cited by this paper
• Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction.

  2003cited by this paper
• Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation.

  2003cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension.

  2003cited by this paper
• Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan.

  2003cited by this paper
• Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.

  2002influential reference
• Aldosterone induces a vascular inflammatory phenotype in the rat heart.

  2002cited by this paper
• Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy.

  2002cited by this paper
• AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats

  2002cited by this paper
• Effects of Long-Term Monotherapy With Eplerenone, a Novel Aldosterone Blocker, on Progression of Left Ventricular Dysfunction and Remodeling in Dogs With Heart Failure

  2002cited by this paper
• Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure.

  2002cited by this paper
• Oxidative Stress Increases Endothelin‐1 Synthesis in Human Coronary Artery Smooth Muscle Cells

  2001cited by this paper
• Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.

  2001cited by this paper
• Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction.

  2001cited by this paper
• Effect of a selective aldosterone receptor antagonist in myocardial infarction.

  2001cited by this paper
• The Endothelin‐Aldosterone Axis and Cardiovascular Diseases

  2001cited by this paper
• ETA Receptor Antagonist Prevents Blood Pressure Elevation and Vascular Remodeling in Aldosterone-Infused Rats

  2001cited by this paper
• Aldosterone Induces Angiotensin-Converting-Enzyme Gene Expression in Cultured Neonatal Rat Cardiocytes

  2001cited by this paper
• Treatment of Congestive Heart Failure: Interfering the Aldosterone-Cardiac Extracellular Matrix Relationship

  2001cited by this paper
• Aldosterone Production Is Activated in Failing Ventricle in Humans

  2001cited by this paper
• Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system.

  2000influential reference
• Angiotensin II receptor blockade attenuates the deleterious effects of exercise training on post-MI ventricular remodelling in rats.

  2000cited by this paper
• Myosin heavy chain isoform expression in the failing and nonfailing human heart.

  2000cited by this paper
• Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure.

  2000cited by this paper
• Effects of angiotensin II AT1-receptor blockade on coronary dynamics, function, and structure in postischemic heart failure in rats.

  2000influential reference
• Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES)

  2000cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• , Brigitte Angiotensin II Receptor Blockade and Role in Cardiac Fibrosis Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction : Effect of

  1999cited by this paper
• Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

  1999cited by this paper
• Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis.

  1999cited by this paper
• Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy

  1998cited by this paper
• Alterations of calcium-regulatory proteins in heart failure.

  1998cited by this paper
• Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation.

  1997cited by this paper
• Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.

  1997cited by this paper
• Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes.

  1996cited by this paper
• The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure.

  1995cited by this paper
• Endocarditis prophylaxis: from experimental models to human recommendation.

  1995cited by this paper
• Structural basis of end-stage failure in ischemic cardiomyopathy in humans.

  1994cited by this paper
• Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.

  1994cited by this paper
• Role of Collagen in Acute Myocardial Infarct Expansion

  1991cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

  1990cited by this paper
• Myocardial Infarct Size and Ventricular Function in Rats

  1979cited by this paper
• Treatment of Congestive Heart Failure Interfering the Aldosterone-cardiac Extracellular Matrix Relationship

  year unknowncited by this paper

• Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

  2024cites this paper
• Phenotypic Spectrum of Subclinical Sarcomere-Related Hypertrophic Cardiomyopathy and Transition to Overt Disease

  2024cites this paper
• Irbesartan May Ameliorate Ventricular Remodeling by Inhibiting CREB-Mediated Cardiac Aldosterone Synthesis in Rats with Myocardial Infarction

  2024cites this paper
• Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms.

  2022cites this paper
• New Perspectives on Sex Steroid and Mineralocorticoid Receptor Signaling in Cardiac Ischemic Injury

  2022cites this paper
• Mineralocorticoid Receptor Antagonist Treatment of Established Pulmonary Arterial Hypertension Improves Interventricular Dependence in SU5416-Hypoxia Rat Model.

  2022cites this paper
• Diverse origins and activation of fibroblasts in cardiac fibrosis.

  2020cites this paper
• VEGF and TNF-α Responses to Acute and Chronic Aerobic Exercise in the Patients with Multiple Sclerosis

  2020cites this paper
• The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction.

  2019cites this paper
• The role of aldosterone and mineralocorticoid receptor antagonists in cardiovascular damage

  2019cites this paper
• Hypertrophic Cardiomyopathy in the Era of Genomic Medicine

  2018cites this paper
• Role of spironolactone in the treatment of heart failure with preserved ejection fraction.

  2018cites this paper
• Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.

  2015cites this paper
• Cardiac remodeling and physical training post myocardial infarction.

  2015cites this paper
• Mineralocorticoids in the heart and vasculature: new insights for old hormones.

  2015cites this paper
• Adrenal Steroid Hormones

  2015cites this paper
• Aldosterone and Cardiovascular Diseases

  2014cites this paper
• Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury

  2014cites this paper
• The cardioprotective effects of mineralocorticoid receptor antagonists.

  2014cites this paper
• Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy

  2014cites this paper
• Renin inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling.

  2013cites this paper
• Left and Right Ventricle Late Remodeling Following Myocardial Infarction in Rats

  2013cites this paper
• A cornerstone of heart failure treatment is not effective in experimental right ventricular failure.

  2013cites this paper
• Chapter 50 – Hypertrophic Cardiomyopathies

  2013cites this paper
• The Transition from Hypertensive Hypertrophy to Left Ventricular Systolic Chamber Decompensation

  2013influential citation
• Exercise and Matrix Metalloproteases in Health and Disease: A Brief Overview

  2013cites this paper
• Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure

  2013cites this paper
• Le rôle de l’aldostérone sur le remodelage structurel pulmonaire et la fonction ventriculaire droite en insuffisance cardiaque congestive

  2012cites this paper
• Additive Amelioration of Oxidative Stress and Cardiac Function by Combined Mineralocorticoid and Angiotensin Receptor Blockers in Postinfarct Failing Hearts

  2012cites this paper
• Targeting the aldosterone pathway in cardiovascular disease

  2012cites this paper
• Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances

  2012cites this paper
• Antiarrhythmic potential of aldosterone antagonists in atrial fibrillation.

  2012cites this paper
• Novel therapeutic approaches to post-infarction remodelling.

  2012cites this paper
• Current aspects of correction of neurohumoral system activity in patients after myocardial infarction.

  2012cites this paper
• The role of aldosterone receptor antagonists in the management of heart failure: An update

  2012cites this paper
• Aldosterone, mineralocorticoid receptor, and heart failure.

  2012cites this paper
• Aerobic Exercise Training–Induced Left Ventricular Hypertrophy Involves Regulatory MicroRNAs, Decreased Angiotensin-Converting Enzyme-Angiotensin II, and Synergistic Regulation of Angiotensin-Converting Enzyme 2-Angiotensin (1-7)

  2011cites this paper
• Hormonal Mechanisms of Cardiac Remodeling in Heart Failure

  2011cites this paper
• Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma

  2011cites this paper
• Pre-clinical data on involvement of mineralocorticoid receptor activation in healing and remodelling post-myocardial infarction

  2011cites this paper
• Corticosteroid hormone action in the cardiovascular system

  2011cites this paper
• Aldosterone Antagonists in Heart Failure

  2011cites this paper
• Genetics and Genomics of Hypertrophic Cardiomyopathy

  2010cites this paper
• Reducing cardiovascular Risk in patients Following MI with eplerenone

  2010cites this paper
• [Improvement of left ventricular function during combined carvedilol, ramipril and spironolactone therapy after myocarditis in patient treated earlier by chemotherapy due to Hodgkin's lymphoma - 3-years follow-up].

  2010cites this paper
• Diagnostic, Prognostic and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy

  2010cites this paper
• Genetic basis of hypertrophic cardiomyopathy

  2010cites this paper
• Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy.

  2009cites this paper
• CHAPTER 61 – Vaccines

  2009cites this paper
• Cardiac corticosteroid receptors mediate the enlargement of the ovine fetal heart induced by chronic increases in maternal cortisol.

  2008cites this paper
• Aldosterone and the autocrine modulation of potassium currents and oxidative stress in the diabetic rat heart

  2008influential citation
• Eplerenone inhibits the intracrine and extracellular actions of angiotensin II on the inward calcium current in the failing heart. On the presence of an intracrine renin angiotensin aldosterone system.

  2008influential citation
• Effects of exercise training on cardiac function and myocardial remodeling in post myocardial infarction rats.

  2008cites this paper
• Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.

  2008cites this paper
• Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.

  2007cites this paper
• Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure.

  2007cites this paper
• Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.

  2007cites this paper
• Aldosteron und Aldosteronrezeptorantagonisten in der Herzinsuffizienztherapie

  2007cites this paper
• Drug Insight: aldosterone-receptor antagonists in heart failure—the journey continues

  2007cites this paper
• UPREGULATION OF ANGIOTENSIN AT 1 a RECEPTORS mRNA IN THE HEART AND RENAL MEDULLA AFTER MYOCARDIAL INFARCTION IN RATS

  2006cites this paper
• IN THE HEART AND RENAL MEDULLA AFTER MYOCARDIAL

  2006cites this paper
• Upregulation of angiotensin AT1a receptors mRNA in the heart and renal medulla after myocardial infarction in rats.

  2006cites this paper
• Hypothalamic Activation in Rats With Ischemia-Induced Heart Failure Novel Effect of Mineralocorticoid Receptor Antagonism to Reduce Proinflammatory

  2006cites this paper
• Novel Effect of Mineralocorticoid Receptor Antagonism to Reduce Proinflammatory Cytokines and Hypothalamic Activation in Rats With Ischemia-Induced Heart Failure

  2006cites this paper
• Role of mineralocorticoid receptor in diabetic vascular disease

  2006cites this paper
• Pozawałowa przebudowa serca - rozstrzeń lewej komory jako potencjalny cel terapeutyczny Remodeling after myocardial infarction - left ventricular dilation as potential therapeutic target

  2005cites this paper